Sensus Healthcare, Inc.
For the period ended Mar 31, 2026. Filed May 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 13, 2026
SRTS$3.30+3.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Loss (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF LOSS
| For the Three Months Ended March 31, | ||
|---|---|---|
| (in thousands, except shares and per share data) | 2026 | 2025 |
| Revenues | $3,394 | $8,344 |
| Cost of sales | 2,403 | 3,990 |
| Gross profit | 991 | 4,354 |
| Operating expenses | ||
| General and administrative | 2,043 | 2,208 |
| Selling and marketing | 1,716 | 2,186 |
| Research and development | 1,590 | 2,606 |
| Total operating expenses | 5,349 | 7,000 |
| Loss from operations | (4,358) | (2,646) |
| Other income: | ||
| Interest income, net | 125 | 184 |
| Other income, net | 125 | 184 |
| Loss before income taxes | (4,233) | (2,462) |
| (Benefit from) provision for income taxes | (1,607) | 110 |
| Net loss | $(2,626) | $(2,572) |
| Net loss per share – basic | $(0.16) | $(0.16) |
| diluted | $(0.16) | $(0.16) |
| Weighted average number of shares used in | ||
| computing net loss per share – basic | 16,462,653 | 16,341,867 |
| diluted | 16,462,653 | 16,341,867 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.